Abstract
Chronic lymphocytic leukemia (CLL) may induce renal complications, which are becoming increasingly common, but in this context the occurrence of minimal change disease (MCD) remains rare. Monoclonal B lymphocytosis (MBL) is a precursor state of CLL and is currently under recognized. Since MBL is seen as a benign disorder that rarely evolves into CLL, screening for MBL is not standardized and does not require any treatment. When reviewing renal disease associated with MBL, there is very scant data in the literature and to date there is no case describing the association between MBL and MCD. Here, we describe the case of a 71-year old woman admitted for nephrotic syndrome (NS). We diagnosed a MBL. Kidney biopsy revealed MCD. Treatment with corticosteroids was introduced but no improvement was observed. Chemotherapy with rituximab and chlorambucil was thus started, leading to complete remission of both MBL and MCD. To our knowledge, this is the first description of the association of MBL and MCD. This case suggests that screening for MBL may have unexpected diagnostic and therapeutic implications in patients presenting with seemingly idiopathic NS.
Similar content being viewed by others
References
Kofman T, Zhang S-Y, Copie-Bergman C, Moktefi A, Raimbourg Q, Francois H et al (2014) Minimal change nephrotic syndrome associated with non-hodgkin lymphoid disorders: a retrospective Study of 18 cases. Medicine (Baltimore) 93:350–358
Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol CJASN 12:332–345
Cambier J-F, Ronco P (2012) Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol CJASN 7:1701–1712
Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J (2013) Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int 84:34–44
Strati P, Nasr SH, Leung N, Hanson CA, Chaffee KG, Schwager SM et al (2015) Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience. Haematologica 100:1180–1188
Poitou-Verkinder A-L, Francois A, Drieux F, Lepretre S, Legallicier B, Moulin B et al (2015) The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma: a 25-year multicenter experience. Plos One 10:e0119156
Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet Lond Engl 2:556–560
Zhang N, Zhao P, Shrestha A, Zhang L, Qu Z, Liu M et al (2014) A higher frequency of CD4+CXCR5+ T follicular helper cells in adult patients with minimal change disease. BioMed Res Int 2014:836157
Alzamora MG, Schmidli M, Hess U, Cathomas R, von Moos R (2006) Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects. Onkologie 29:153–156
Scrivener S, Goddard RV, Kaminski ER, Prentice AG (2003) Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 44:383–389
Jhaveri KD, Shah HH, Patel C, Kadiyala A, Stokes MB, Radhakrishnan J (2014) Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Adv Chronic Kidney Dis 21:48–55
Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y et al (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164
Strati P, Shanafelt TD (2015) Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 126:454–462
King C, Logan S, Smith SW, Hewins P (2017) The efficacy of rituximab in adult frequently relapsing minimal change disease. Clin Kidney J 10:16–19
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H et al.: Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446–5456
Fermand J-P, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA et al (2013) How I treat monoclonal gammopathy of renal significance (MGRS). Blood 122:3583–3590
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest to declare.
Ethical approval
All procedures performed were in accordance with the ethical standards of our institution, and the 1964 Helsinki declaration and its later amendments.
Informed consent
Written informed consent to publication was obtained.
Rights and permissions
About this article
Cite this article
Wynsberghe, M.V., Lenain, P., Drieux, F. et al. Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?. J Nephrol 31, 317–320 (2018). https://doi.org/10.1007/s40620-017-0464-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-017-0464-0